• 1. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 2. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 3. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 4. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 5. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Research Brief on 2-Bromo-1-(4-bromo-3-fluoro-phenyl)ethanone (CAS: 1003879-02-4): Recent Advances and Applications in Chemical Biology and Medicine

2-Bromo-1-(4-bromo-3-fluoro-phenyl)ethanone (CAS: 1003879-02-4) is a halogenated aromatic ketone that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a key intermediate in the synthesis of various bioactive molecules, particularly those targeting kinase inhibition and covalent protein modification. Recent studies have explored its utility in drug discovery, chemical probe development, and material science, highlighting its importance in advancing therapeutic innovations.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the compound's role as a precursor for irreversible kinase inhibitors, showcasing its reactivity with cysteine residues in ATP-binding pockets. The research team utilized 2-bromo-1-(4-bromo-3-fluoro-phenyl)ethanone to develop a series of selective EGFR inhibitors with improved pharmacokinetic properties. The electron-withdrawing effects of the bromo and fluoro substituents were found to enhance the electrophilicity of the carbonyl carbon, facilitating efficient covalent bond formation with target proteins.

In parallel developments, a 2024 ACS Chemical Biology publication reported the use of this compound in creating activity-based protein profiling (ABPP) probes. The researchers capitalized on its dual reactivity - the α-bromo ketone moiety for protein labeling and the aromatic halogens for subsequent click chemistry modifications. This approach enabled comprehensive mapping of cysteine-reactive proteomes in cancer cell lines, revealing several previously uncharacterized drug targets.

The compound's crystallographic characteristics were recently elucidated in a Chemical Communications article (2024), providing crucial structural insights for rational drug design. The crystal structure revealed a planar conformation stabilized by intramolecular halogen interactions between the bromine at position 4 and the fluorine atom, explaining its enhanced stability compared to analogous compounds. These findings have important implications for the development of more stable drug candidates and chemical probes.

From a synthetic chemistry perspective, recent advances in green chemistry have explored more sustainable routes to produce 2-bromo-1-(4-bromo-3-fluoro-phenyl)ethanone. A 2023 Green Chemistry paper described a photocatalytic bromination method that reduces hazardous waste generation by 60% while maintaining high yield (82%) and purity (>98%). This development addresses growing concerns about the environmental impact of halogenated compound synthesis in pharmaceutical manufacturing.

Emerging applications in materials science have also been reported, particularly in the development of organic electronic materials. The compound's strong electron-accepting properties, attributed to its halogen substituents, make it a promising building block for organic semiconductors. A 2024 Advanced Materials study demonstrated its incorporation into donor-acceptor polymers with exceptional charge transport properties, opening new avenues for bioelectronic devices.

In conclusion, 2-bromo-1-(4-bromo-3-fluoro-phenyl)ethanone continues to prove its value as a multifunctional chemical building block in biomedical research. Recent studies have expanded its applications from traditional medicinal chemistry to cutting-edge areas like chemical proteomics and bioelectronics. Future research directions likely include further optimization of its synthetic accessibility, exploration of new biological targets, and development of novel material applications. The compound's unique combination of reactivity and stability positions it as a valuable tool for addressing complex challenges in chemical biology and drug discovery.

• 53631-18-8(2-Bromo-1-(3-fluorophenyl)ethan-1-one)
• 594810-90-9(2-bromo-1-(2-bromo-4-fluorophenyl)ethanone)
• 869569-77-7(2-Bromo-1-(4-bromo-2-fluorophenyl)ethanone)
• 435273-49-7(2-Bromo-1-(3-bromo-4-fluorophenyl)ethanone)
• 1204333-47-0(3-Bromo-2-fluorophenacyl Bromide)
• 1007-15-4(1-(3-bromo-4-fluorophenyl)ethan-1-one)
• 1379358-71-0(2-Bromo-1-(3-bromo-5-fluorophenyl)ethanone)
• 304445-49-6(1-(4-bromo-3-fluorophenyl)ethan-1-one)
• 916792-04-6(1-(4-bromo-3-fluorophenyl)propan-1-one)
• 1427413-65-7(5-Bromo-2-fluorophenacyl bromide)